MAP2K7 and neoplasm: It is considered that growth factors and cytokines produced by cancer cells within the tumor microenvironment might activate G-CSF in tumor and stromal cells because activation of the RAS/RAF/MEK pathway resulted in enhanced G-CSF expression [29].